Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
- PMID: 30201753
- PMCID: PMC12392993
- DOI: 10.1212/WNL.0000000000005929
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
Erratum for
-
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.Neurology. 2018 May 15;90(20):e1805-e1814. doi: 10.1212/WNL.0000000000005516. Epub 2018 Apr 25. Neurology. 2018. PMID: 29695594 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources